Risk assessment of readmissions following an initial COPD-related hospitalization
Christine L Baker,1 Kelly H Zou,1 Jun Su2 1Pfizer Inc, New York, NY, USA; 2Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA Background: Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a leading cause of hospitalizations and readmissions in the US. Reducing the freq...
Main Authors: | Baker CL, Zou KH, Su J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-11-01
|
Series: | International Journal of COPD |
Online Access: | http://www.dovepress.com/risk-assessment-of-readmissions-following-an-initial-copd-related-hosp-a14965 |
Similar Items
-
Readmission After COPD Exacerbation Scale: determining 30-day readmission risk for COPD patients
by: Lau CSM, et al.
Published: (2017-06-01) -
Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data
by: Baker CL, et al.
Published: (2014-05-01) -
Predicting and preventing hospital readmission for exacerbations of COPD
by: Chia Wei Kong, et al.
Published: (2020-05-01) -
Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD
by: Bollu V, et al.
Published: (2013-12-01) -
Risk for hospital readmission following bariatric surgery.
by: Robert B Dorman, et al.
Published: (2012-01-01)